Fidia Pharma USA Inc
Paul Ammermuller currently serves as District Manager at Fidia Pharma USA Inc since June 2017. Previously, Paul held the position of District Sales Manager at Endo Pharmaceuticals, where leadership was demonstrated in the launch of a novel pain medication. Paul's extensive experience at Eisai US spanned from September 2001 to March 2016, including multiple roles such as District Manager and Sr Manager Leadership Development, showcasing a strong track record in sales team leadership and product launches within the neurology specialty. Paul began a career in sales training, progressively advancing through various management roles. Educational credentials include a BS in Biology from St. Bonaventure University, earned between 1976 and 1980.
This person is not in any offices
Fidia Pharma USA Inc
Fidia Pharma USA Inc is a wholly-owned subsidiary of the Italian pharmaceutical manufacturer Fidia Farmaceutici S.p.A., an established leader in the hyaluronic acid (HA) market segment. Fidia Pharma USA is focused on continually expanding Fidia’s position in the U.S. and Canadian market, while upholding the company's mission to provide consumers with innovative products that offer quality, safety and performance, establishing a sound strategic presence of Fidia in the US consistently with the Company's mission and strategy pillars. Drawing on the strengths of the parent company, Fidia Pharma USA product portfolio focuses primarily on therapeutic areas such as joint healthcare and tissue repair. Fidia Pharma USA Inc is headquartered in Parsippany, NJ.